Phocas Financial Corp. Sells 67,470 Shares of Encompass Health Co. (NYSE:EHC)

Phocas Financial Corp. cut its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 85.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,911 shares of the company's stock after selling 67,470 shares during the quarter. Phocas Financial Corp.'s holdings in Encompass Health were worth $1,100,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. MassMutual Private Wealth & Trust FSB boosted its stake in Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after acquiring an additional 137 shares in the last quarter. Avior Wealth Management LLC acquired a new position in Encompass Health during the third quarter worth $40,000. Tompkins Financial Corp acquired a new position in Encompass Health during the fourth quarter worth $46,000. V Square Quantitative Management LLC raised its holdings in Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after buying an additional 177 shares during the last quarter. Finally, Morse Asset Management Inc acquired a new position in Encompass Health during the third quarter worth $68,000. 97.25% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have weighed in on EHC shares. Barclays upped their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, February 7th. Royal Bank of Canada restated an "outperform" rating and set a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. KeyCorp upped their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. StockNews.com upgraded shares of Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. Finally, William Blair restated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Ten investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Encompass Health has a consensus rating of "Buy" and an average target price of $107.67.

Remove Ads

Encompass Health Stock Down 0.2 %

Shares of EHC stock traded down $0.23 on Friday, hitting $100.11. The stock had a trading volume of 946,339 shares, compared to its average volume of 658,075. The business has a 50 day moving average of $96.42 and a 200 day moving average of $96.29. The stock has a market cap of $10.09 billion, a price-to-earnings ratio of 22.45, a price-to-earnings-growth ratio of 2.31 and a beta of 0.90. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. Encompass Health Co. has a 12-month low of $73.68 and a 12-month high of $104.55.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, analysts expect that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 17th. Investors of record on Tuesday, April 1st will be given a dividend of $0.17 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.68%. Encompass Health's payout ratio is currently 15.25%.

Insider Activity at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 2.10% of the stock is owned by company insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.